Archives for February 2009

February 2009 - Page 10 of 11 - Money Morning - Only the News You Can Profit From

Global Investment News Briefs

Pending Home Resales Climb; Dow Chemical Posts Steep Loss; Motorola Suspends Dividend, Lowers Forecast; Bank of Japan Buying Local Bank Shares; Automakers Suffer Through Worst Month Since 1982; AIG Shares Hit All-Time Low; Private Equity Firms Say Large LBO Market Dead; Brazil's Economy in Recession Demand may be rising in the housing market, as the […]

Read More…

Sprott: Gold Prices Could Double Amid a U.S. Depression

By Don MillerAssociate EditorMoney Morning Respected Canadian money manager Eric Sprott predicted gold prices will more than double over the next few years as the U.S enters a full-blown depression. Sprott, who correctly predicted the collapse of banking stocks, made the comments yesterday (Tuesday) during an interview with Bloomberg News. The United States could be […]

Read More…

Global Investment News Briefs

Manufacturing Spending Continue Slide; Macy's Cuts 7,000 Jobs; Banks Still Not Lending; Renew Energy Files for Bankruptcy; Morgan Stanley Slashes Workforce; Oil Prices Slide 4%; Steelcase Shows Weakness Manufacturing in the U.S. shrank again last month and consumer spending recorded an unprecedented sixth monthly decline in January. The Institute for Supply Management's factory index was […]

Read More…

China Considers Expanding Stimulus to Combat Unemployment

By Jason Simpkins Managing Editor Money Morning In an interview with the Financial Times yesterday (Monday), Chinese Premier Wen Jiabao said his government is ready to expand on the $586 billion (2 trillion yuan) stimulus package it unveiled late last year. The reason: Soaring unemployment and the threat of social unrest. A recent government survey […]

Read More…

Hot Stocks: Pfizer-Wyeth Merger Underscores That Bigger isn't Better, Takeover Expert Basenese Says

By William Patalon IIIExecutive EditorMoney Morning/The Money Map Report Pfizer Inc (PFE) plan to buy rival U.S. drugmaker Wyeth (WYE) for about $68 billion is a case of “the dead buying the dying,” and won’t provide the revenue growth that Pfizer needs and is seeking, top takeover expert Louis Basenese says. The New York, N.Y.-based […]

Read More…